Monday, June 17, 2024
Facebook Linkedin Twitter
HomeTagsTomosynthesis

tomosynthesis

Healthcare

Therapixel receives FDA clearance for use of its AI-based breast cancer screening software MammoScreen® on Digital Breast Tomosynthesis

PR Newswire -
Therapixel, a company leading the use of AI-based products for women's health, announces it has received a second 510(k) clearance from the U.S. Food...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us